COLL
Collegium Pharmaceutical, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
28.15
close · 2026-08-13
value
94
cheaper than peers94
quality
64
stronger fundamentals64
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 3.92× | 98 |
| forward P/E | 4.04× | 94 |
| price to sales | 1.19× | 89 |
| price to book | 2.93× | 60 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 27.4% | 84 |
| operating margin | 16.0% | 72 |
| revenue growth | 8.9% | 55 |
| debt to equity | 297.6% | 19 |
4 of 4 measures available
Facts
| market cap | $913M |
| free cash flow | $332.6M |
| employees | 423 |
| first trade | 2015-05-07 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-06 |